Obtenga las últimas noticias sobre las acciones de RAPT Therapeutics con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de RAPT

Últimas noticias sobre

RAPT THERAPEUTICS INC

RAPT Therapeutics

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Inc

Earnings

Press Releases

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

News

RAPT Therapeutics to Participate in Upcoming Investor Conferences

Health Care

Management

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development

RAPT Therapeutics Reports First Quarter 2025 Financial Results

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

Small Cap

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy

RAPT

ADC Therapeutics

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Aura Biosciences

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Benitec Biopharma

Cellectis S.A. - American Depositary Shares

Cellectis

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences

Design Therapeutics

enGene Holdings

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Immuneering Corporation - Class A Common Stock

Immuneering

Jade Biosciences

Kamada

Keros Therapeutics

Korro Bio

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lexeo Therapeutics

Neurogene

ProKidney Corp. - Class A Ordinary Shares

ProKidney

PureTech Health plc - American Depositary Shares

PureTech Health

Rocket Pharmaceuticals, Inc. - Common Stock

Comments

RAPT Therapeutics Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL